|
US5968547A
(en)
|
1997-02-24 |
1999-10-19 |
Euro-Celtique, S.A. |
Method of providing sustained analgesia with buprenorphine
|
|
US20020102291A1
(en)
*
|
1997-12-15 |
2002-08-01 |
Noven Pharmaceuticals, Inc. |
Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
|
|
GB9913458D0
(en)
*
|
1999-06-09 |
1999-08-11 |
Medeva Europ Ltd |
The therapeutic use of d-threo-methylphenidate
|
|
GB9918735D0
(en)
*
|
1999-08-09 |
1999-10-13 |
Straken Limited |
Transdermal patches
|
|
CO5261532A1
(es)
*
|
1999-11-15 |
2003-03-31 |
Novartis Ag |
Compuestos heterociclicos sililados, procedimiento para la preparacion de estos y composicion farmaceutica que los contiene
|
|
AU2199901A
(en)
*
|
1999-12-17 |
2001-06-25 |
Medeva Europe Limited |
The treatment of convulsive states
|
|
US6455066B1
(en)
|
2000-03-10 |
2002-09-24 |
Epicept Corporation |
Intradermal-penetration agents for topical local anesthetic administration
|
|
US6905016B2
(en)
*
|
2000-03-14 |
2005-06-14 |
Noven Pharmaceuticals, Inc. |
Packaging system for transdermal drug delivery systems
|
|
US7674480B2
(en)
*
|
2000-06-23 |
2010-03-09 |
Teva Pharmaceutical Industries Ltd. |
Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
|
|
US20020119187A1
(en)
*
|
2000-09-29 |
2002-08-29 |
Cantor Adam S. |
Composition for the transdermal delivery of fentanyl
|
|
DE10060550C1
(de)
*
|
2000-12-06 |
2002-04-18 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit dem Wirkstoff Oxybutynin und Verfahren zur Herstellung Oxybutynin enthaltender Wirkstoffschichten
|
|
ES2559666T3
(es)
*
|
2001-03-07 |
2016-02-15 |
Hisamitsu Pharmaceutical Co., Inc. |
Parche adhesivo
|
|
FR2822049B1
(fr)
*
|
2001-03-13 |
2003-08-01 |
Dbv Medica 1 |
Patch destine notamment a depister l'etat de sensibilisation d'un sujet a un allergene, procede de fabrication et utilisation
|
|
ES2270746T3
(es)
*
|
2001-03-16 |
2007-12-01 |
Alza Corporation |
Parche transdermico para administrar fentanilo.
|
|
US20050208117A1
(en)
*
|
2001-03-16 |
2005-09-22 |
Venkatraman Subramanian S |
Transdermal administration of fentanyl and analogs thereof
|
|
DE10141650C1
(de)
*
|
2001-08-24 |
2002-11-28 |
Lohmann Therapie Syst Lts |
Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
|
|
DE10141652B4
(de)
*
|
2001-08-24 |
2011-04-07 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
|
|
US20030049272A1
(en)
*
|
2001-08-30 |
2003-03-13 |
Yatindra Joshi |
Pharmaceutical composition which produces irritation
|
|
JP4354678B2
(ja)
*
|
2002-08-28 |
2009-10-28 |
久光製薬株式会社 |
貼付剤
|
|
US6913768B2
(en)
|
2002-09-24 |
2005-07-05 |
Shire Laboratories, Inc. |
Sustained release delivery of amphetamine salts
|
|
ATE482695T1
(de)
|
2002-12-13 |
2010-10-15 |
Durect Corp |
Orale darreichungsform mit flüssigen hochviskosen trägersystemen
|
|
CA2542778C
(en)
*
|
2003-10-28 |
2012-05-29 |
Noven Pharmaceuticals, Inc. |
Transdermal drug delivery composition
|
|
NZ556456A
(en)
|
2005-01-20 |
2010-12-24 |
Inst Molecular Medicine Inc |
Methylphenidate derivatives and uses of them
|
|
HRP20110779T1
(hr)
*
|
2005-01-20 |
2011-12-31 |
Institute For Molecular Medicine |
Upotrebe derivata metilfenidata
|
|
CA2633599C
(en)
*
|
2005-12-23 |
2015-02-10 |
Epinamics Gmbh |
Use of film-forming hair-care polymers from the group of polyurethanes and pharmaceutical preparations and plasters containing said polymers
|
|
US9393218B2
(en)
*
|
2005-12-23 |
2016-07-19 |
Epinamics Gmbh |
Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers
|
|
CA2643037C
(en)
*
|
2006-02-27 |
2014-08-05 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for delivery of amino-functional drugs
|
|
AU2007248284B2
(en)
*
|
2006-05-01 |
2011-03-17 |
Colgate-Palmolive Company |
Oral care composition with silicone composite
|
|
CA2678806C
(en)
*
|
2007-02-21 |
2017-05-16 |
Connected Health Systems, Llc |
Treating adhd and other diseases involving inflammation
|
|
MY154027A
(en)
*
|
2007-10-15 |
2015-04-30 |
Alza Corp |
Once-a-day replacement transdermal administration of fentanyl
|
|
FR2924349B1
(fr)
|
2007-12-03 |
2010-01-01 |
Dbv Tech |
Methode de desensibilitation aux allergenes
|
|
FR2924350B1
(fr)
*
|
2007-12-03 |
2010-08-13 |
Dbv Tech |
Procede et compositions pour la vaccination par voie cutanee
|
|
EP2219622A1
(en)
|
2007-12-06 |
2010-08-25 |
Durect Corporation |
Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
|
|
CA2711174A1
(en)
*
|
2007-12-31 |
2009-07-16 |
Acclarent, Inc. |
Mucosal tissue dressing and method of use
|
|
FR2926466B1
(fr)
*
|
2008-01-23 |
2010-11-12 |
Dbv Tech |
Procede de fabrication de patchs par electrospray
|
|
JP5856843B2
(ja)
|
2008-05-27 |
2016-02-10 |
アンピオ ファーマシューティカルズ，インコーポレイテッド |
ジケトピペラジンを用いた医薬組成物
|
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
|
JP5155128B2
(ja)
*
|
2008-12-11 |
2013-02-27 |
日東電工株式会社 |
メチルフェニデート貼付製剤
|
|
CA3172541C
(en)
*
|
2009-06-05 |
2026-04-14 |
Durr Systems, Inc. |
Improved infrared float bar
|
|
EP2364695A1
(en)
|
2010-02-10 |
2011-09-14 |
Nitto Denko Corporation |
Methylphenidate patch preparation
|
|
US20110200663A1
(en)
*
|
2010-02-12 |
2011-08-18 |
Nitto Denko Corporation |
Methylphenidate patch preparation
|
|
US8916588B2
(en)
|
2011-03-23 |
2014-12-23 |
Ironshore Pharmaceuticals & Development, Inc. |
Methods for treatment of attention deficit hyperactivity disorder
|
|
US9603809B2
(en)
|
2011-03-23 |
2017-03-28 |
Ironshore Pharmaceuticals & Development, Inc. |
Methods of treatment of attention deficit hyperactivity disorder
|
|
US9283214B2
(en)
|
2011-03-23 |
2016-03-15 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
|
US10292937B2
(en)
|
2011-03-23 |
2019-05-21 |
Ironshore Pharmaceuticals & Development, Inc. |
Methods of treatment of attention deficit hyperactivity disorder
|
|
US10905652B2
(en)
|
2011-03-23 |
2021-02-02 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
|
US8927010B2
(en)
|
2011-03-23 |
2015-01-06 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
|
US11241391B2
(en)
|
2011-03-23 |
2022-02-08 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
|
US9119809B2
(en)
|
2011-03-23 |
2015-09-01 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
|
AU2012230733B2
(en)
|
2011-03-23 |
2016-10-20 |
Ironshore Pharmaceuticals & Development, Inc. |
Methods and compositions for treatment of attention deficit disorder
|
|
US9498447B2
(en)
|
2011-03-23 |
2016-11-22 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
|
CA3123900A1
(en)
*
|
2011-07-28 |
2013-01-31 |
Kempharm Inc. |
Methylphenidate-prodrugs, processes of making and using the same
|
|
AR092999A1
(es)
|
2012-10-15 |
2015-05-13 |
Noven Pharma |
Composiciones y metodos para la administracion transdermica de metilfenidato
|
|
US9265458B2
(en)
|
2012-12-04 |
2016-02-23 |
Sync-Think, Inc. |
Application of smooth pursuit cognitive testing paradigms to clinical drug development
|
|
WO2014106014A1
(en)
|
2012-12-28 |
2014-07-03 |
Noven Pharmaceuticals, Inc |
Transdermal drug delivery systems for levonorgestrel and ethinyl estradiol
|
|
AU2013370297A1
(en)
|
2012-12-28 |
2015-07-16 |
Noven Pharmaceuticals, Inc. |
Multi-polymer compositions for transdermal drug delivery
|
|
US9380976B2
(en)
|
2013-03-11 |
2016-07-05 |
Sync-Think, Inc. |
Optical neuroinformatics
|
|
US11337936B2
(en)
|
2013-03-14 |
2022-05-24 |
Noven Pharmaceuticals, Inc. |
Amphetamine transdermal compositions with acrylic block copolymer
|
|
AR095259A1
(es)
|
2013-03-15 |
2015-09-30 |
Noven Pharma |
Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria
|
|
TW201521769A
(zh)
|
2013-03-15 |
2015-06-16 |
Durect Corp |
具有流變改質劑以減少溶解變異性之組成物
|
|
AR095260A1
(es)
|
2013-03-15 |
2015-09-30 |
Noven Pharma |
Composiciones de anfetaminas transdérmicas estables y métodos de fabricación
|
|
CA2932301A1
(en)
|
2013-12-25 |
2015-07-02 |
Fujimoto Co., Ltd. |
Prophylactic and therapeutic agent for attention-deficit/hyperactivity disorder
|
|
US9980921B2
(en)
*
|
2016-06-30 |
2018-05-29 |
Taho Pharmaceuticals Ltd. |
Transdermal delivery system containing methylphenidate or its salts and methods thereof
|
|
SG11201811760VA
(en)
|
2016-07-06 |
2019-01-30 |
Durect Corp |
Oral dosage form with drug composition, barrier layer and drug layer
|
|
CN106511264A
(zh)
*
|
2016-11-15 |
2017-03-22 |
北京万全德众医药生物技术有限公司 |
一种盐酸哌甲酯口服溶液剂及其制备方法
|
|
HUE067004T2
(hu)
|
2016-12-11 |
2024-10-28 |
Zevra Therapeutics Inc |
Metilfenidát prodrogokat tartalmazó készítmények, eljárások azok elõállítására és felhasználására
|
|
EP3598982A1
(en)
|
2018-07-23 |
2020-01-29 |
Centre National De La Recherche Scientifique |
Bioconjugates of neuropeptides derivatives
|
|
JP7600661B2
(ja)
*
|
2020-12-11 |
2024-12-17 |
ａｒｔｉｅｎｃｅ株式会社 |
貼付剤
|